Filing Details

Accession Number:
0001615219-22-000087
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-31 17:17:24
Reporting Period:
2022-05-26
Accepted Time:
2022-05-31 17:17:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1615219 Salarius Pharmaceuticals Inc. SLRX Pharmaceutical Preparations (2834) 465087339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1769331 J. David Arthur C/O Salarius Pharmaceuticals, Inc.
2450 Holcome Blvd., Suite X
Houston TX 77021
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-26 3,400 $0.18 263,074 No 4 P Direct
Common Stock Acquisiton 2022-05-26 18,600 $0.18 281,674 No 4 P Direct
Common Stock Acquisiton 2022-05-26 708 $0.18 282,382 No 4 P Indirect By son
Common Stock Acquisiton 2022-05-26 10,392 $0.18 292,774 No 4 P Indirect By son
Common Stock Acquisiton 2022-05-26 10,800 $0.18 303,574 No 4 P Indirect By daughter
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Indirect By son
No 4 P Indirect By son
No 4 P Indirect By daughter
Footnotes
  1. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.